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http:WHAT THIS PAPER ADDS
This article has reviewed the literature for studies evaluating the changes in cognitive function after carotid
artery stenting (CAS) versus carotid endarterectomy (CEA). The majority of the 13 studies that were identiﬁed
did not demonstrate a signiﬁcant difference between the two procedures with regard to an effect on cognitive
function. However, the lack of standardization of speciﬁc cognitive tests and timing of assessment of cognitive
function after CAS and CEA do not allow for deﬁnite conclusions to be drawn. Future studies should address the
limitations of the previous studies and systematically evaluate the effect of CAS and CEA on cognitive function.The effect of carotid artery stenting (CAS) and carotid endarterectomy (CEA) on cognitive function is unclear.
Both cognitive improvement and decline have been reported after CAS and CEA. We aimed to compare the
changes in postprocedural cognitive function after CAS versus CEA. A systematic qualitative review of the
literature was conducted according to the recommendations of the Preferred Reporting Items for Systematic
Reviews and Meta-analysis statement for studies evaluating the changes in cognitive function after CAS
compared with CEA. Thirteen studies (403 CEAs; 368 CAS procedures) comparing the changes in cognitive
function after CEA versus CAS were identiﬁed. Most studies did not show signiﬁcant differences in overall
cognitive function or only showed a difference in a single cognitive test between the two procedures. A deﬁnitive
conclusion regarding the effect of CAS versus CEA on cognitive function was not possible owing to heterogeneity
in deﬁnition, method, timing of assessment, and type of cognitive tests. For the same reasons, performing a
meta-analysis was not feasible. The lack of standardization of speciﬁc cognitive tests and timing of assessment of
cognitive function after CAS and CEA do not allow for deﬁnite conclusions to be drawn. Larger, adequately-
powered and appropriately designed studies are required to accurately evaluate the effect of CAS versus CEA on
postprocedural cognitive function.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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It has previously been reported that carotid endarterec-
tomy (CEA) and carotid artery stenting (CAS) are effective
procedures for the prevention of stroke in patients with
carotid artery stenosis.1,2 The effect of CAS and CEA on
cognitive function, however, is controversial. The term
“cognitive function” includes a variety of functions, such
as verbal and non-verbal memory, attention, executive
function, mood, language, and motor skills. A cross-
sectional, cohort study on 4,006 patients without arresponding author. K.I. Paraskevas, Department of Vascular Surgery,
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//dx.doi.org/10.1016/j.ejvs.2013.11.006history of a cerebrovascular event reported that a 75%
internal carotid artery stenosis is associated with an
almost sevenfold increased risk of cognitive impairment
and an almost threefold increased risk of cognitive
decline.3 These results suggest that even asymptomatic
carotid artery stenosis is strongly associated with cognitive
impairment and decline.3 Some studies have demon-
strated cognitive improvement after both CEA4 and CAS,5,6
whereas others have shown no change7,8 or even cogni-
tive decline.9,10
A systematic review on the effects of CAS and CEA on
cognitive function, a few years ago, concluded that neither
procedure clearly affected cognition.11 This systematic re-
view included 25 articles evaluating cognitive function af-
ter CEA, four after CAS, and only three studies comparing
the effects of CAS versus CEA on cognitive performance
(113 CEAs vs. 94 angioplasty/CAS procedures).11 The
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CEA or CAS were inconsistent. Some reports showed
improvement, others did not show any substantial change,
while others reported deterioration in cognitive function
after either procedure.11 The three studies directly
comparing CAS and CEA were all performed within two
randomized, controlled trials, that is, two within the Ca-
rotid And Vertebral Artery Transluminal Angioplasty Study
(CAVATAS)12,13 and the third within the Stent-Protected
Angioplasty versus Carotid Endarterectomy (SPACE)14
study.
The studies included in this early systematic review11 had
several limitations. One limitation of the ﬁrst two reports
from CAVATAS12,13 was that all endovascular procedures
but one were performed by angioplasty alone (i.e., without
the use of a stent). Another limitation of all three studies12e
14 was that an embolic protection device (EPD) was not
used routinely. CAS is associated with higher microembolic
event rates than CEA.10,15 EPDs successfully reduce the
number of microembolic events after CAS.15 An EPD was
only used in 151 of the 567 patients (27%) in SPACE14 and in
none of the patients participating in CAVATAS.12,13 Finally,
the number of patients included in these three sub-
studies12e14 was small because only a small subgroup of the
overall randomized population in CAVATAS (46/504 pa-
tients)13 and SPACE (45/1,183 patients)14 was analyzed for
cognitive performance. The results of this early systematic
review11 regarding the possible effects of CAS versus CEA on
cognitive function may therefore be inaccurate and not up-
to-date. Since the publication of the previous systematic
review,11 several more recent studies have compared the
effects of CAS versus CEA on cognitive function. We
therefore updated this early systematic review11 to inves-
tigate the current status regarding the effects of CAS versus
CEA on cognitive function.METHODS
This systematic review was conducted according to the
recommendations of the Preferred Reporting Items for
Systematic Reviews and Meta-analysis (PRISMA) state-
ment.16 The PRISMA checklist with a related appendix
(participants, interventions, comparisons, outcomes, and
study design) are shown in Fig. 1. We sought to identify all
studies comparing the pre- and postoperative cognitive
performance and cognitive function after CAS versus CEA
that were published up to 15 August 2013. The PubMed/
Medline, Cochrane and Embase (1974epresent) databases
were searched using the following terms: “carotid artery
stenting”, “carotid endarterectomy”, “carotid revasculariza-
tion”, “cognitive function”, and “cognitive test” in various
combinations. The reference lists of the gathered reports
were manually searched. This produced additional studies,
which were also considered.
Studies were included if they compared the cognitive
function pre- and postoperatively after CAS versus CEA, and
included at least 10 patients in each group. Studies assessing
the cognitive function after CAS or CEA alone were excluded.
Case reports, review articles, and letters were also excluded
from analysis. Articles from the same authors were included
when they reported additional information that was not
included in the previous report, such as different tests,
measurements, and different patients.
The search was independently performed by two in-
vestigators (K.I.P. and C.L.) and was completed on 15 August
2013. The data were checked independently for quality. The
methodological quality of individual observational studies
was assessed with the NewcastleeOttawa Scale (NOS),17 a
validated instrument speciﬁcally designed to evaluate the
quality of observational studies in systematic reviews and
meta-analyses.18,19 The NOS evaluates three domains of
224 K.I. Paraskevas et al.study methodology: the selection of study groups (score
range: 0e4), the comparability of groups (score range: 0e
1), and the quality of ascertainment of either the exposures
(for case-control studies) or of the outcomes of interest (for
cohort studies; score range: 0e3). The composite NOS score
ranges from 0 to 8, with a NOS score >5 indicating an
acceptable methodological design. For the randomized
controlled trials included in this review, the methodological
quality was assessed using the Cochrane Collaborations risk
of bias assessment tool.20Mesh terms used: Carotid artery s
37 artic
                                                                                       
                                                                                       
Studies evaluating cognitive  
function after CAS alone: 16
Studies evaluating cognitive                    
                  function after CAS vs. CEA: 8              eva
Mesh terms used: Carotid endarter
104 arti
Studies evaluating cognitive                                         
function after CEA alone: 61
Studies comparing CAS vs. CEA: 8                             
                                                                              (e.g. r
                                          Inappropriate studies 
                         (e.g. evaluating changes in molecular l
Figure 2. Flow chartRESULTS
A total of 37 reports were identiﬁed using the mesh terms
“carotid artery stenting AND cognitive function”. Another
104 articles were identiﬁed when the mesh terms “carotid
endarterectomy AND cognitive function” were used. The
combinations “carotid revascularization AND cognitive
function” and “carotid revascularization AND cognitive test”
produced 31 and 16 articles, respectively. These last two
searches did not produce any additional articles relevant to
the topic beyond the results of the ﬁrst two searches, andtenting AND cognitive function
les 
                                  Other types of articles 
         (e.g. review articles, case reports, letters): 7
   Inappropriate studies (e.g. 
luating changes in molecular level): 6
ectomy AND cognitive function 
cles 
                          Studies evaluating cognitive 
function after CAS alone: 4
     Other types of articles 
eview articles, letters, case reports): 20
evel): 11
of search results.
Table 1. Studies comparing cognitive outcomes after carotid artery stenting (CAS) versus carotid endarterectomy (CEA).
Study (year) Patient groups Timing of assessment Outcome
Sivaguru et al. (1999)12,a 63 symptomatic CEA
vs. 53 PTA patients
Before and 6 mo after the procedure No signiﬁcant difference the overall score between PTA and CEA
Crawley et al. (2000)13,a 26 symptomatic CEA
vs. 20 PTA patients
Before, 6 wks after and 6 mo
after the procedure
No signiﬁcant differences tween the two groups on any test at any of
the assessment times. Th nly signiﬁcant difference was found with
the Grooved Pegboard (d inant hand), with CEA patients performing
better at the 6-mo asses ent compared with PTA (0.45 vs. 0.06,
respectively; p ¼ 0.047)
Witt et al. (2007)14,b 21 symptomatic CAS
vs. 24 CEA patients
Before, 6 d after and 1 mo
after the procedure
There were no difference etween CAS and CEA in any
neuropsychological outco
Gossetti et al. (2007)10,b 50 CEA vs. 50 CAS patients
(mixed population)
Before, at discharge and 2 mo
after the procedure
 Microemboli were de ted in 37 CEA (74%) and all 50 (100%)
CAS procedures
 Cognitive capability w ened in 18 patients after CAS (36%)
and 2 after CEA (4%)
Jansen et al. (2008)27,a 17 symptomatic CAS patients
vs. 10 CEA patients vs.
13 healthy controls
Before, 1 mo, and 6 mo after
the procedure
 No difference in mem function (p ¼ 0.241) and alertness
(p ¼ 0.220) between ients undergoing CAS vs. CEA
 Memory function and rtness at 6 mo deteriorated in
both groups compare ith healthy controls (for CEA vs.
controls: p ¼ 0.041; f CAS vs. controls: p ¼ 0.003)
Takaiwa et al. (2009)25,a 11 CEA vs. 15 CAS patients
(mixed population)
Preoperatively, 1 wk, 3 mo, 6 mo,
and 1 y postoperatively
 Both CEA and CAS de nstrated improved RBANS
scores 3 mo postoper ely (for CAS: from 86.3  11.0
to 100.3  10.8; p < 1; for CEA: from 93.4  12.5 to
106.8  15.3; p < 0.0 which persisted at 1 y
 CAS patients showed roved MMSE scores 1 wk
postoperatively (from .7  1.3 to 28.5  1.6; p < 0.01),
whereas CEA patients owed improved MMSE scores 6
mo postoperatively (f 28.0  1.5 to 28.9  0.7; p < 0.01)
Capoccia et al. (2010)28,b 20 asymptomatic CEA
vs. 23 CAS patients
Preoperatively, 24 h postoperatively,
and 6 mo after the procedure
 For CEA patients, the an MMSE scores decreased non-
signiﬁcantly (from 26. 3.46 to 25.6  3.27; p ¼ 0.67)
 For CAS patients, the an MMSE scores decreased
signiﬁcantly (from 25. 4.46 to 22.9  4.54; p ¼ 0.045)
 Between-group analys showed a signiﬁcant decrease in
the postoperative sco of CAS vs. CEA patients (p ¼ 0.03)
 At the 6-mo follow-up he MMSE score showed an
improvement in CAS p ients (23.7  4.58), while it was
stable in the CEA grou (25.9  3.43; within- and
between-group analys ¼ NS)
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Table 1-continued
Study (year) Patient groups Timing of assessment Outcome
Feliziani et al. (2010)21,b 22 asymptomatic CEA
vs. 24 CAS patients
Preoperatively (T0), at 3 (T3)
and 12 (T12) mo postoperatively
 No signiﬁcant nces were observed at T0, T3, and
T12 between C d CAS patients (for CEA: from
27.8  2.3 to 2.4 and 27.6  3.0; for CAS:
from 27.2  1 6.5  2.8 and 27.7  2.1)
 CAS showed w utcomes in the trail-making
test part A com with CEA (preoperatively:
52.9  24.4 vs  37.7, for CEA vs. CAS,
respectively; p 58; at 3 mo: 63.2  50 vs.
109.2  74.4, A vs. CAS, respectively;
p < 0.05; at 1 55.6  22.5 vs. 97.2  51.0,
for CEA vs. CA ectively; p < 0.01)
Lal et al. (2011)22,b 25 asymptomatic CEA
vs. 21 CAS patients
1e3 d before and 4e6 mo after
CEA/CAS
 The composite e score for the entire test battery
improved in p both after CEA and after CAS
compared with baseline values (þ0.51 for CEA vs.þ0.47
for CAS, respe ; p ¼ NS)
 CEA resulted i terioration of working memory index
(a measureme emory/concentration), while CAS
improved it (c score: 0.41 vs. 0.46, for CEA vs. CAS,
respectively; p 01)
 CAS resulted i terioration of the Processing Speed Index
(a measureme sychomotor speed), while CEA improved
it (change sco .32 vs. 0.58, respectively; p ¼ 0.001)
Altinbas et al. (2011)23,a 61 symptomatic CAS
vs. 58 CEA patients
1 wk before and 6 mo after
the procedure
 From baseline o follow-up there was a signiﬁcant decrease
in the cognitiv score after CAS of 0.19 (95% CI: 0.10e0.29;
p < 0.0001) a on-signiﬁcant decrease after CEA of 0.02
(95% CI: 0.1 21; p ¼ 0.825)
 Mean differen .17 (95% CI: 0.38 to 0.03; p ¼ 0.092)
 Within the ind l domains, the unadjusted change in the
cognitive dom tract reasoning was signiﬁcantly worse
after CAS (diff between changes: 0.22; 95% CI: 0.44
to 0.00; p ¼ 0 but after adjustment for age, sex, and
education this t stay statistically signiﬁcant. The lack
of a difference nition between CAS with CEA may be
explained by i ient statistical power
Wasser et al. (2012)29,b 1 d before, 1e4 d after, and
3 mo after the procedure
 Patients < 68 ot show any signiﬁcant cognitive
alteration afte r CEA or CAS
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19 CAS vs. 27 CEA
patients (mixed
population)
 Patients  68 y treated by CAS demonstrated a signiﬁcant
deterioration in post- v pre-procedural scores (p ¼ 0.01),
but then their cognitive performance improved by
3 months (p ¼ 0.017)
 Patients  68 y treated by CEA demonstrated a signiﬁcant
deterioration in post- v pre-procedural scores (p ¼ 0.022),
which persisted at 6 m (p ¼ 0.002)
Zhou et al. (2012)24,b 16 CAS and 35 CEA patients
(mixed population)
1e2 wks before and 1 mo
after the procedure
 Microemboli after the ocedure were found in 8 CAS (50%)
and 3 CEA (8.6%) patie ts
 There was a trend for a decrease in mean RAVLT scores
for patients with proce re-related microemboli
(from 37.2  12 to 29.  9.3; p ¼ 0.0525), whereas
those without microem oli had a slightly increased RAVLT
mean score (from 33.3 8.8 to 34.2  9.4; p ¼ NS)
Capoccia et al. (2012)26,b 32 asymptomatic CEA
vs. 28 CAS patients
Preoperatively, 1 d, 6 mo and
12 mo postoperatively
 New ischemic lesions w re detected in 6 CAS vs. 1 CEA
patients (21.4% vs. 3%, espectively; p ¼ 0.03)
 In CAS patients, new D -MRI lesions were associated
with MMSE score decli (p ¼ 0.001)
 At 12 months, patients resenting with new lesions
showed lower MMSE s res (p ¼ 0.08)
Note. PTA ¼ percutaneous transluminal angioplasty; RBANS ¼ Repeatable Battery for the Assessment of Neuropsychological Status; MMS ¼ Mini-Mental State Examination; NS ¼ non-
signiﬁcant; CI ¼ conﬁdence interval; RAVLT ¼ Rey Auditory Verbal Learning Curve; DW-MRI ¼ diffusion-weighted magnetic resonance im ing.
a Randomized controlled trial.
b Non-randomized trial.
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Table 2. Quality of observational studies (NewcastleeOttawa
Scale).17
Study Selection
(0e4)a
Comparability
(0e1)b
Outcome/
exposure
(0e3)c
Total
Gossetti et al.10 4 0 1 5
Takaiwa et al.25 4 0 2 6
Capoccia et al.28 4 1 3 8
Feliziani et al.21 4 1 3 8
Lal et al.22 3 1 2 6
Wasser et al.29 4 1 2 7
Zhou et al.24 4 1 0 5
Capoccia et al.26 4 0 2 6
Note. Maximum score ¼ 8, minimum ¼ 0.
a For cohort studies, “selection” refers to the representativeness of
the exposed cohort (yes ¼ 1, no ¼ 0), selection of the non-
exposed cohort (adequate ¼ 1, inadequate ¼ 0), ascertainment
of exposure (clear ¼ 1, unclear ¼ 0), and demonstration that the
outcome of interest was not present at the beginning of the study
(yes ¼ 1, no ¼ 0). For case-control studies, “selection” refers to the
case deﬁnition (adequate ¼ 1, inadequate ¼ 0), representative-
ness of the cases (yes ¼ 1, no ¼ 0), selection of controls
(adequate ¼ 1, inadequate ¼ 0), and deﬁnition of controls
(adequate ¼ 1, inadequate ¼ 0).
b For cohort studies, “comparability” refers to adjustment for bias/
confounding (yes ¼ 1, no ¼ 0). For case-control studies,
“comparability” refers to adjustment for bias/confounding
(yes ¼ 1, no ¼ 0).
c “Outcome” refers to outcome assessment, i.e., independent
blind assessment (yes ¼ 1, no ¼ 0), appropriate duration of follow
up (yes ¼ 1, no ¼ 0), and adequacy of follow-up (>90% ¼ 1, 
90% ¼ 0). “Exposure” assessment refers to ascertainment of
exposure (adequate ¼ 1, inadequate ¼ 0); identical method of
ascertainment for cases and controls (yes ¼ 1, no ¼ 0), and non-
response rate (same rate for both groups ¼ 1, other ¼ 0).
228 K.I. Paraskevas et al.were therefore ignored. The search of the Cochrane and
Embase databases did not produce any additional studies.
The ﬂow chart of the ﬁrst two search results is presented
in Fig. 2. Eight articles comparing cognitive functions after
CAS versus CEA were identiﬁed.10,14,21e26 Another ﬁve ar-
ticles were retrieved12,13,27e29 by searching the reference
lists of these full-text articles,10,14,21e26 as well as by
including the studies of the earlier published systematic
review.11
The ﬁndings of these 13 studies10,12e14,21e29 (403 CEAs;
368 CAS procedures) are presented in Table 1. Six studiesTable 3. Cochrane Collaborations’ tool20 for assessing risk of bias in ra
Study Random
sequence
generation
Allocation
concealment
Blinding of
participants
and personn
Sivaguru et al.12 ? ? ?
Crawley et al.13 þ þ e
Witt et al.14 þ ? e
Altinbas et al.23 þ þ e
Jansen et al.27 þ ? e
Note. (þ) ¼ low risk of bias; (e) high risk of bias; (?) ¼ unclear risk ofailed to show a signiﬁcant overall difference in cognitive
functions between CAS and CEA.12e14,21e23 Some of these
studies demonstrated a difference in only one of the spe-
ciﬁc cognitive function tests between the two procedures
(e.g., the Trail Making Test,21 the Processing Speed Index,22
or the Grooved Pegboard).13 Other studies showed a sig-
niﬁcant deterioration in cognitive functions after CAS, but
not after CEA.23,26,28 One study showed a deterioration in
one cognitive domain (working memory index) after CEA,
but not after CAS.22 Another study suggested that patients
aged 68 years (but not younger individuals) may
demonstrate differences in cognitive functions when un-
dergoing CAS or CEA.29 In this study, patients undergoing
both CEA and CAS demonstrated postoperative deteriora-
tion in cognitive function. While this decline in cognitive
function improved 3 months after CAS, it persisted 6
months after CEA.29
The methodological quality of the observational studies
included, was acceptable, with all studies achieving a NOS
score >5 (Table 2). Among randomized controlled trials,
two studies had an overall low risk of bias,13,23 whereas the
study by Sivaguru et al.12 has only been available in abstract
form (Table 3).
Unfortunately, there was considerable heterogeneity in
the 13 studies10,12e14,21e29 identiﬁed. For instance, in one
study,12 assessment of cognitive functions was performed
before and 6 months after the procedure; in another13
before, 6 weeks, and 6 months after the procedure; while
in a third study,14 this was performed before, 6 days after,
and then at 1 month after the procedure. A fourth study
assessed the cognitive function preoperatively, and 1 week,
3 months, 6 months, and 1 year postoperatively,25 while a
ﬁfth study assessed cognition preoperatively, 24 hours
postoperatively, and 6 months after carotid revasculariza-
tion.28 There was also considerable heterogeneity regarding
the types of test used to assess cognitive function (e.g., the
Mini-Mental State Examination,21,24e26,28 the Repeatable
Battery for the Assessment of Neuropsychological Status,25
or the Rey Auditory Verbal Learning Curve24). Furthermore,
some studies included only symptomatic patients,12e14,23,27
some other studies included only asymptomatic in-
dividuals,21,22,26,28 and others included both symptomatic
and asymptomatic carotid patients.10,24,25,29 Finally, the
studies range over a relatively long period (from 199911 to
201224,26), and most of them include few (<50) pa-
tients.13,14,21,22,25,27e29ndomized controlled trials.
el
Blinding of
outcome
assessment
Incomplete
outcome data
Selective
reporting
Other
bias
? ? ? e
þ þ þ ?
? þ þ ?
þ þ þ þ
? þ ? ?
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Our literature search revealed ﬁve randomized controlled
trials12e14,23,27 and eight non-randomized trials10,21,22,24e
26,28,29 comparing cognitive function changes after CAS
versus CEA. Owing to the heterogeneity in deﬁnition,
methods, type of tests, and time of assessment of cognitive
function, the data from this systematic review could not be
combined in a formal meta-analysis. This was in accordance
with the PRISMA statement.16 Overall, a clear difference in
postprocedural cognitive function after CAS compared with
CEA could not be demonstrated.
Several mechanisms have been postulated to explain the
changes in cognitive function after CAS or CEA. Some
studies4e6 support that the improvement in cognitive
function after CAS or CEA is owing to the fact that carotid
revascularization procedures correct the cerebral hypo-
perfusion resulting from carotid artery stenosis. In contrast,
the mechanisms providing possible explanations for the
cognitive decline after carotid revascularization include ce-
rebral emboli and hypoperfusion generated during the
procedure.10,15 CAS is associated with a higher incidence of
embolization10,15 and stroke30 rates compared with surgery.
It was suggested that the difference in embolization rates
between the two procedures may account for the differ-
ence in cognitive function.10,24 However, if this mechanism
could explain the postprocedural differences in cognitive
function between CAS and CEA, all studies would produce
similar results in favor of CEA. Thus, this mechanism may
account for the difference in cognitive function in certain
cases, but not in others.
Whether or not the higher embolization rates after CAS
compared with CEA are responsible for a greater cognitive
decline is a subject for debate. The arguments supporting
this theory derive from studies on patients undergoing
coronary artery bypass grafting (CABG).31,32 Cerebral emboli
generated during CABG are responsible for postoperative
cognitive deﬁcits in these patients.31,32 A similar mechanism
has thus been postulated for patients undergoing CAS.10,15
In contrast, others have claimed that the higher incidence
of microemboli after CAS compared with CEA is not asso-
ciated with a greater cognitive decline.33
A recent study evaluated the association between
asymptomatic cerebral lesions on diffusion-weighted mag-
netic resonance imaging (DW-MRI) after CAS with post-
operative cognitive function in 37 patients.34 This study
demonstrated that CAS-induced new postprocedural
asymptomatic cerebral ischemic lesions on DW-MRI had a
negative impact on cognitive functions.34 This report
conﬁrmed the results of an earlier study10 demonstrating an
increased rate of cognitive dysfunction in patients with
higher microemboli rates after CAS compared with CEA.
Therefore, preliminary evidence suggests that the higher
embolization rates after CAS compared with CEA may pre-
dispose patients to higher post-procedural cognitive
dysfunction.34 This association should be veriﬁed in larger
studies in the future before a deﬁnitive conclusion can be
drawn.This review has several limitations. A major limitation is
that the studies included may not be adequately powered
to assess with certainty the effects of CAS and CEA on
cognitive function. A second limitation is that current
guidelines recommend the performance of both CEA and
CAS within 2 weeks of the development of cerebrovascular
symptoms.2,35 Future studies should assess changes in
cognitive function when the carotid revascularization pro-
cedure is performed within 2 weeks of the index symptom.
Another limitation is that the cognitive tests employed, the
duration of follow-up, and the time intervals between the
assessment points vary considerably between studies.
Consequently, at this time, it is not possible to reach a
deﬁnite conclusion regarding the effects of carotid revas-
cularization on cognitive function. Future studies should
address these limitations and should systematically evaluate
the changes in cognitive functions after CAS and CEA.
CONCLUSIONS
The studies comparing the outcomes after CEA and CAS
always report stroke and death rates, but rarely measure
the effects of these procedures on cognitive functions. This
systematic review aimed to compare cognition before and
after CAS versus CEA. There is marked inconsistency in the
literature regarding the effect of CAS and CEA on cognitive
function. The studies so far produce mixed and heteroge-
neous results, and thus do not allow for accurate conclu-
sions to be drawn. Standardization of neuropsychological
testing, follow-up timing, and incorporation of neuro-
imaging could all enhance the ability of further clinical
studies to investigate the effect of carotid interventions on
cognitive function and to elucidate the underlying patho-
physiology. Besides stroke and death rates, CAS and CEA
should also be compared with regard to their effect on
postprocedural cognitive function.
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